André Verwei

Commercial Services

Health Technology

Profile

André Verwei worked as the Chief Financial Officer at Amsterdam Molecular Therapeutics (AMT) Holding NV and as the Head-Finance at ProQR Therapeutics NV.

Former positions of André Verwei

Companies	Position	End
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.	Director of Finance/CFO	2009-11-30
PROQR THERAPEUTICS N.V.	Director of Finance/CFO	-

See the detail of André Verwei's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies